Armistice Capital »

Cellebrite Di Ltd Ordinary Shares shares owned by Armistice Capital

Quarter-by-quarter ownership of Cellebrite Di Ltd Ordinary Shares (CLBT) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Cellebrite Di Ltd Ordinary Shares

Tip: Access up to 7 years of quarterly data

All positions including Cellebrite Di Ltd Ordinary Shares held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellebrite Di Ltd Ordinary Shares by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $184k 17k 11.08

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital

Top funds holding Cellebrite Di Ltd Ordinary Shares

IGP Investments
True Wind Capital Management
Clal Insurance Enterprises Holdings
Morgan Stanley
Crosslink Capital
Phoenix Holdings
Acadian Asset Management
Greenhaven Road Investment Management
Ashford Capital Management
Voss Capital
Meitav Dash Investments
Arrowstreet Capital, Limited Partnership
BlackRock
Millennium Management
Marshall Wace

View all funds holding Cellebrite Di Ltd Ordinary Shares